Interaction between tumor-associated dendritic cells and colon cancer cells contributes to tumor progression via CXCL1
YL Hsu, YJ Chen, WA Chang, SF Jian, HL Fan… - International journal of …, 2018 - mdpi.com
Crosstalk of a tumor with its microenvironment is a critical factor contributing to cancer
development. This study investigates the soluble factors released by tumor-associated …
development. This study investigates the soluble factors released by tumor-associated …
CXCL8 associated dendritic cell activation marker expression and recruitment as indicators of favorable outcomes in colorectal cancer
Accumulating evidence suggests that tumor-infiltrating immune cells (TICs) in the tumor
microenvironment (TME) serve as promising therapeutic targets. CXCL8 (IL-8) may also be …
microenvironment (TME) serve as promising therapeutic targets. CXCL8 (IL-8) may also be …
CXCL12/CXCR4 promotes inflammation-driven colorectal cancer progression through activation of RhoA signaling by sponging miR-133a-3p
X Yu, D Wang, X Wang, S Sun, Y Zhang… - Journal of Experimental …, 2019 - Springer
Abstract Background Activation of CXCL12/CXCR4 axis has been found to be associated
with invasion and metastasis in many cancers. However, the underlying mechanism remains …
with invasion and metastasis in many cancers. However, the underlying mechanism remains …
Enrichment of colorectal cancer stem cells through epithelial-mesenchymal transition via CDH1 knockdown
Cancer stem cells (CSCs) are considered to be the origin of cancer relapse and metastasis.
The better understanding of CSCs, including CSCs in human colorectal cancer (CRC), may …
The better understanding of CSCs, including CSCs in human colorectal cancer (CRC), may …
Chemokine (C‐C motif) ligand 5 is involved in tumor‐associated dendritic cell‐mediated colon cancer progression through non‐coding RNA MALAT‐1
JY Kan, DC Wu, FJ Yu, CY Wu, YW Ho… - Journal of cellular …, 2015 - Wiley Online Library
Tumor micro‐environment is a critical factor in the development of cancer. The aim of this
study was to investigate the inflammatory cytokines secreted by tumor‐associated dendritic …
study was to investigate the inflammatory cytokines secreted by tumor‐associated dendritic …
[HTML][HTML] Differential role of CXCR3 in inflammation and colorectal cancer
Chemokines (CXCR3) and their ligands (CXCL9, CXCL10, and CXCL11) exert exquisite
control over T-cell trafficking and are critical for activation, differentiation and effector T cell …
control over T-cell trafficking and are critical for activation, differentiation and effector T cell …
Tumor-derived CXCL5 promotes human colorectal cancer metastasis through activation of the ERK/Elk-1/Snail and AKT/GSK3β/β-catenin pathways
J Zhao, B Ou, D Han, P Wang, Y Zong, C Zhu, D Liu… - Molecular cancer, 2017 - Springer
Background Metastasis is a major cause of death in human colorectal cancer patients.
However, the contribution of chemokines in the tumor microenvironment to tumor metastasis …
However, the contribution of chemokines in the tumor microenvironment to tumor metastasis …
Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer
AJ Michielsen, AE Hogan, J Marry, M Tosetto, F Cox… - PloS one, 2011 - journals.plos.org
Inflammatory mediators in the tumour microenvironment promote tumour growth, vascular
development and enable evasion of anti-tumour immune responses, by disabling infiltrating …
development and enable evasion of anti-tumour immune responses, by disabling infiltrating …
Human MSCs promotes colorectal cancer epithelial–mesenchymal transition and progression via CCL5/β-catenin/Slug pathway
K Chen, Q Liu, LL Tsang, Q Ye, HC Chan, Y Sun… - Cell death & …, 2017 - nature.com
Mesenchymal stem cells (MSCs) extensively interact with cancer cells and other stroma cells
in the tumor microenvironment. However, the role of MSCs in colorectal cancer (CRC) …
in the tumor microenvironment. However, the role of MSCs in colorectal cancer (CRC) …
Colon cancer therapy by focusing on colon cancer stem cells and their tumor microenvironment
Despite many advances and optimization in colon cancer treatment, tumor recurrence and
metastases make the development of new therapies necessary. Colon cancer stem cells …
metastases make the development of new therapies necessary. Colon cancer stem cells …